Study looks at genetic background of healthy people who develop severe Covid-19 illness

June 13, 2020 – To help disentangle the secrets of Covid-19 disease, researchers are sequencing the DNA of young grown-ups and children who suffer from extreme Covid-19 disease ailments in spite of having no hidden clinical issues. The scientists are searching for hereditary genetic risk factors that could put certain people at high danger of getting seriously sick from the novel coronavirus, i.e., SARS-CoV-2.. 

The McDonnell Genome Institute at Washington University School of Medicine in St. Louis is one of in excess of 30 genome sequencing centers overall taking an interest in these examinations. In the US, besides at  Washington University, the collaborative worldwide initiative called the COVID Human Genetic Effort (CHGE), is co-driven by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), and Rockefeller University.

The scientists additionally plan to contemplate individuals who never become tainted with SARS-CoV-2, the infection that causes Covid-19, in spite of rehashed exposures. Such people may have hereditary varieties that secure against disease. For instance, certain uncommon hereditary variations are known to impede a few kinds of viral contaminations, including HIV and norovirus. Information picked up from comprehension Covid-19’s limits such as unordinary weakness could prompt new restorative procedures for the disease. 

The main focal point of the researchers examination will be patients with extreme clinical reactions to SARS-CoV-2 infections, sufficiently serious to require concentrated clinical intervention and who are younger than 50 years. Such patients generally don’t have uncontrolled diabetes, coronary illness, incessant lung infection or other preexisting conditions that are known to expand the danger of serious complexities from Covid-19. Effectively, one learns about a long distance runner or a for the most part fit and well trained individual who became seriously ill from SARS-CoV-2 infection, or about a series of young and healthy kids who were becoming extremely ill with Covid-19, all without any hidden or overt predispositions for disease. These are the sorts of patients for research on genetic backgrounds as reasons for severe Covid-19 disease in young patients. Likely less than 10 % of all patients affected by Covid-19 will meet such clinical preselection criteria.

Particular risk for young people for Covid-19 disease may relate to existing yet hidden genetic predispositions for essential immunodeficiencies. To find such genetic risk loci, ideally, genome wide association studies (GWAS) encompassing populations of carefully selected patients exhibiting the searched for clinical endpoint(s), i.e., any forms of immunodeficiencies in the present setting,  would be the approach of choice. In fact, GWAS have recently shown their power to reveal genetic predispotions of patients for SARS-CoV-2 based Covid-19 development. Thus, in one of the first GWAS-studies, variants in both the ABO blood group locus and a cluster of genes on human chromosome 3 have been found to be more common among Covid-19 patients with respiratory failure than in the general population. Similarly, susceptibility loci in pathways of immune system function may be localised. Furthermore, more prospective evidence for patients susceptibilities will emerge from within the COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.

Eventually, these concerted genetic approaches will lead to a sound body of understanding around SARS-CoV-2 and Covid-19, and how individuals may cope with this distinctive health challenge.

See here a sequence on susceptibility particularly looking at Covid-19:

Print Friendly, PDF & Email


Tags: , , , , , , , ,
About the Author
Joseph Gut - thasso Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Your opinion


No comments yet

thasso: conditions

thasso: newest tweets

thasso: recent comments

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Genetic determinants of fertility and ongoing natural selection in humans October 29, 2020
    An international team of researchers who identified genetic variants associated with reproductive success say their findings could highlight mechanisms underlying fertility and infertility. In addition, their analyses detected genetic alleles under present-day selection, providing an insight into the nature of ongoing natural selection in humans. Iain Mathieson, Ph.D., a population geneticist at the University of […]
  • Cancer-fighting gene restrains 'jumping genes' October 29, 2020
    About half of all tumors have mutations of the gene p53, normally responsible for warding off cancer. Now, UT Southwestern scientists have discovered a new role for p53 in its fight against tumors: preventing retrotransposons, or "jumping genes," from hopping around the human genome. In cells with missing or mutated p53, the team found, retrotransposons […]
  • Genomic study reveals role for hypothalamus in inflammatory bowel disease October 29, 2020
    Using sophisticated 3-D genomic mapping and integrating with public data resulting from genome-wide association studies (GWAS), researchers at Children's Hospital of Philadelphia (CHOP) have found significant genetic correlations between inflammatory bowel disease (IBD) and stress and depression. The researchers went on to implicate new genes involved in IBD risk that are enriched in both derived […]
  • Study identifies pitfall for correcting mutations in human embryos with CRISPR October 29, 2020
    In a paper published today in the journal Cell, scientists describe unexpected, undesirable outcomes after editing genes in human embryos with CRISPR, a genomic editing system.
  • Spread of a novel SARS-CoV-2 variant across Europe in summer 2020 October 29, 2020
    Researchers from Basel and Spain have identified a novel SARS-CoV-2 variant that has spread widely across Europe in recent months, according to an un-peer-reviewed preprint released this week. While there is no evidence of this variant being more dangerous, its spread may give insights into the efficacy of travel policies adopted by European countries during […]